$TRNS
TRANSCAT INC Stock $trns

$trns Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000120677421002699 Filed on November 03, 2021

Income Statement

Concept	2021 Q3	2020 Q3	2020 Q2
Revenue	$50.39M	$41.61M	$38.90M
YoY Change	21.1%	-0.37%	-8.23%
Cost Of Revenue	$35.78M	$30.11M	$29.50M
YoY Change	18.81%	-3.85%	-8.81%
Gross Profit	$14.61M	$11.49M	$9.409M
YoY Change	27.12%	10.04%	-6.4%
Gross Profit Margin	29.0%	27.63%	24.19%
Selling, General & Admin	$10.31M	$8.416M	$8.445M
YoY Change	22.53%	13.95%	4.34%
% of Gross Profit	70.58%	73.22%	89.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.141M	$1.870M	$1.872M
YoY Change	14.49%	11.31%	15.41%
% of Gross Profit	14.65%	16.27%	19.9%
Operating Expenses	$11.03M	$8.416M	$8.445M
YoY Change	31.1%	13.95%	4.34%
Operating Profit	$3.578M	$3.078M	$964.0K
YoY Change	16.24%	0.62%	-50.77%
Interest Expense	-$169.0K	-$230.0K	-$220.0K
YoY Change	-26.52%	-4.17%	-8.33%
% of Operating Profit	-4.72%	-7.47%	-22.82%
Other Income/Expense, Net	-$250.0K	-$317.0K	-$243.0K
YoY Change	-21.14%	6.73%	-14.74%
Pretax Income	$3.328M	$2.761M	$721.0K
YoY Change	20.54%	-0.04%	-56.9%
Income Tax	$313.0K	$737.0K	-$77.00K
% Of Pretax Income	9.41%	26.69%	-10.68%
Net Earnings	$3.015M	$2.024M	$798.0K
YoY Change	48.96%	-14.92%	-53.55%
Net Earnings / Revenue	5.98%	4.86%	2.05%
Basic Earnings Per Share	$0.40	$0.27	$0.11
Diluted Earnings Per Share	$397.0K	$0.27	$0.11
COMMON SHARES
Basic Shares Outstanding	7.482M shares	7.417M shares	7.394M shares
Diluted Shares Outstanding	7.595M shares	7.549M shares	7.514M shares

Balance Sheet

Concept	2021 Q3	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.551M	$1.000M	$400.0K
YoY Change	155.1%	11.11%	-33.33%
Cash & Equivalents	$2.551M	$962.0K	$366.0K
Short-Term Investments
Other Short-Term Assets	$4.105M	$2.400M	$1.900M
YoY Change	71.04%	0.0%	11.76%
Inventory	$10.21M	$13.69M	$14.19M
Prepaid Expenses
Receivables	$36.46M	$27.65M	$27.85M
Other Receivables	$448.0K	$717.0K	$894.0K
Total Short-Term Assets	$53.77M	$45.38M	$45.25M
YoY Change	18.49%	-1.99%	-2.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$31.43M	$21.48M	$20.87M
YoY Change	46.34%	-24.91%	-22.41%
Goodwill	$59.44M	$41.77M	$41.68M
YoY Change	42.3%
Intangibles	$12.75M	$6.737M	$7.349M
YoY Change	89.3%
Long-Term Investments
YoY Change
Other Assets	$919.0K	$685.0K	$733.0K
YoY Change	34.16%	-14.38%	4.71%
Total Long-Term Assets	$104.5M	$80.68M	$78.92M
YoY Change	29.57%	17.44%	17.09%
TOTAL ASSETS
Total Short-Term Assets	$53.77M	$45.38M	$45.25M
Total Long-Term Assets	$104.5M	$80.68M	$78.92M
Total Assets	$158.3M	$126.1M	$124.2M
YoY Change	25.59%	9.62%	9.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.98M	$11.06M	$9.326M
YoY Change	-0.65%	-0.41%	-29.35%
Accrued Expenses	$8.455M	$7.100M	$6.600M
YoY Change	19.08%	12.7%	-2.94%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.134M	$2.024M	$2.003M
YoY Change	5.43%	6.53%	5.42%
Total Short-Term Liabilities	$21.57M	$20.64M	$17.92M
YoY Change	4.54%	6.37%	-18.56%
LONG-TERM LIABILITIES
Long-Term Debt	$40.92M	$20.71M	$26.52M
YoY Change	97.58%	-8.77%	30.02%
Other Long-Term Liabilities	$10.17M	$3.345M	$2.682M
YoY Change	203.92%	-57.12%	-66.48%
Total Long-Term Liabilities	$51.08M	$24.05M	$29.21M
YoY Change	112.37%	-21.13%	2.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$21.57M	$20.64M	$17.92M
Total Long-Term Liabilities	$51.08M	$24.05M	$29.21M
Total Liabilities	$77.57M	$55.96M	$56.71M
YoY Change	38.62%	6.99%	6.99%
SHAREHOLDERS EQUITY
Retained Earnings		$48.62M	$46.59M
YoY Change
Common Stock		$22.17M	$21.71M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$80.74M	$70.10M	$67.46M
YoY Change
Total Liabilities & Shareholders Equity	$158.3M	$126.1M	$124.2M
YoY Change	25.59%	9.62%	9.2%

Cashflow Statement

Concept	2021 Q3	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	$3.015M	$2.024M	$798.0K
YoY Change	48.96%	-14.92%	-53.55%
Depreciation, Depletion And Amortization	$2.141M	$1.870M	$1.872M
YoY Change	14.49%	11.31%	15.41%
Cash From Operating Activities	$5.447M	$8.440M	$4.042M
YoY Change	-35.46%	330.61%	362.47%
INVESTING ACTIVITIES
Capital Expenditures	-$2.567M	-$1.860M	$1.261M
YoY Change	38.01%	-28.46%	-12.79%
Acquisitions
YoY Change
Other Investing Activities	-$19.98M		$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$22.55M	-$1.860M	-$1.261M
YoY Change	1112.15%	-47.46%	-0.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$904.0K
YoY Change			-7.47%
Debt Paid & Issued, Net			$487.0K
YoY Change			4.28%
Cash From Financing Activities	19.12M	-5.700M	-$2.721M
YoY Change	-435.47%	-411.48%	-817.94%
NET CHANGE
Cash From Operating Activities	5.447M	8.440M	$4.042M
Cash From Investing Activities	-22.55M	-1.860M	-$1.261M
Cash From Financing Activities	19.12M	-5.700M	-$2.721M
Net Change In Cash	2.023M	880.0K	-$133.0K
YoY Change	129.89%	252.0%	-20.36%
FREE CASH FLOW
Cash From Operating Activities	$5.447M	$8.440M	$4.042M
Capital Expenditures	-$2.567M	-$1.860M	$1.261M
Free Cash Flow	$8.014M	$10.30M	$2.781M
YoY Change	-22.19%	125.88%	-586.19%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000099302
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-28
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3328000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2761000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6822000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3482000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	24885000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1		USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1		USD
	trns	Accrued Contingent Consideration Related To Acquisition AccruedContingentConsiderationRelatedToAcquisition	153000	USD
	trns	Accrued Contingent Consideration Related To Acquisition AccruedContingentConsiderationRelatedToAcquisition		USD
	trns	Accrued Estimated Working Capital Adjustment Related To Acquisition AccruedEstimatedWorkingCapitalAdjustmentRelatedToAcquisition	226000	USD
	trns	Accrued Estimated Working Capital Adjustment Related To Acquisition AccruedEstimatedWorkingCapitalAdjustmentRelatedToAcquisition		USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	20910000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24680000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3116000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	24511000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-6632000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1021000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	979000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1238000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	474000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5649000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1287000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19079000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8424000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	90000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-473000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1991000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	463000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	560000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	499000	USD
	us-gaap	Interest Paid Net InterestPaidNet	357000	USD
	us-gaap	Interest Paid Net InterestPaidNet	466000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1531000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	332000	USD
	us-gaap	Stock Issued1 StockIssued1	2368000	USD
	us-gaap	Stock Issued1 StockIssued1		USD
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	2159000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	67087000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	383000	USD
CY2020Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1287000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	91000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	312000	USD
CY2020Q2	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	163000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	798000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	67456000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	366000	USD
CY2020Q3	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	165000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2024000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	70102000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	75078000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	699000	USD
CY2021Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3377000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	437000	USD
CY2021Q2	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	182000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	3688000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	76707000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2907000	USD
CY2021Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2272000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	620000	USD
CY2021Q3	trns	Other Comprehensive Income Loss Net Of Taxes OtherComprehensiveIncomeLossNetOfTaxes	-233000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3015000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	80744000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1100000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	USD
CY2021Q1	us-gaap	Investments Investments	400000	USD
CY2021Q3	us-gaap	Investments Investments	400000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	100000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-100000	USD
CY2021Q3	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	3100000	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	120000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7549000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7578000	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	111000	shares
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-37000	USD
	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings	0.02
	trns	Dilutive Securities Effect Per Share On Earnings DilutiveSecuritiesEffectPerShareOnEarnings
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7482000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7417000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7473000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7405000	shares
CY2021Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	113000	shares
CY2020Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	132000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	105000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7595000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7525000	shares
CY2020Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	38000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	131000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56000	shares
CY2021Q1	us-gaap	Goodwill Goodwill	43272000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7513000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	16206000	USD
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	6690000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1349000	USD
	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-101000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	59441000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12753000	USD
	trns	Leverage Ratio Of Debt LeverageRatioOfDebt	1.54	pure
CY2021	trns	Leverage Ratio Of Debt LeverageRatioOfDebt	0.94	pure
	trns	Discrete Benefits Related To Sharebased Compensation Awards DiscreteBenefitsRelatedToSharebasedCompensationAwards	1700000	USD
	trns	Discrete Benefits Related To Sharebased Compensation Awards DiscreteBenefitsRelatedToSharebasedCompensationAwards	300000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	125000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.47
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	125000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	59.87
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	85000	shares
	us-gaap	Gross Profit GrossProfit	20903000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	11033000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	8416000	USD
	us-gaap	Operating Expenses OperatingExpenses	20864000	USD
	us-gaap	Operating Expenses OperatingExpenses	16861000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3578000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	3078000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	12.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000	shares
	us-gaap	Operating Income Loss OperatingIncomeLoss	7267000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4042000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-250000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-317000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	24.30
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	160000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	51.72
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2045000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	26.27
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P8Y
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	76000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	item
CY2021Q3	us-gaap	Revenues Revenues	50387000	USD
CY2020Q3	us-gaap	Revenues Revenues	41607000	USD
	us-gaap	Revenues Revenues	98177000	USD
	us-gaap	Revenues Revenues	80511000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	14611000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	11494000	USD
	us-gaap	Gross Profit GrossProfit	28131000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-445000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-560000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	313000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	737000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	119000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	660000	USD
CY2021Q3	us-gaap	Other General Expense OtherGeneralExpense	563000	USD
CY2020Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	2891000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	7360000	USD
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3237000	USD
CY2020Q3	us-gaap	Other General Expense OtherGeneralExpense	1054000	USD
	us-gaap	Other General Expense OtherGeneralExpense	564000	USD
	us-gaap	Other General Expense OtherGeneralExpense	1220000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	3015000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	2024000	USD
	us-gaap	Net Income Loss NetIncomeLoss	6703000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2822000	USD
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	51989000	USD
CY2020Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	43821000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	102109000	USD
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	84060000	USD
CY2021Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	3342000	USD
CY2021Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.45
CY2020Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.39
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.98
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.44
CY2021Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.44
CY2020Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.38
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.97
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.43

Files In Submission

Name	View Source	Status
0001206774-21-002699-index-headers.html	Edgar Link	pending
0001206774-21-002699-index.html	Edgar Link	pending
0001206774-21-002699.txt	Edgar Link	pending
0001206774-21-002699-xbrl.zip	Edgar Link	pending
e14152ex10-2.htm	Edgar Link	pending
e14152ex10-3.htm	Edgar Link	pending
e14152ex10-5.htm	Edgar Link	pending
e14152ex31-1.htm	Edgar Link	pending
e14152ex31-2.htm	Edgar Link	pending
e14152ex32-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transcat3973051-10q.htm	Edgar Link	pending
transcat3973051-10q_htm.xml	Edgar Link	completed
trns-20210925.xsd	Edgar Link	pending
trns-20210925_cal.xml	Edgar Link	unprocessable
trns-20210925_def.xml	Edgar Link	unprocessable
trns-20210925_lab.xml	Edgar Link	unprocessable
trns-20210925_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRNS
TRANSCAT INC Stock $trns

2021 Q3 Form 10-Q Financial Statement

#000120677421002699 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS TRANSCAT INC Stock $trns

2021 Q3 Form 10-Q Financial Statement

#000120677421002699 Filed on November 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRNS
TRANSCAT INC Stock $trns